SHANGHAI, China, May 6 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. , a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it will release unaudited financial results for the first quarter 2008 after the US market close on Tuesday, May 27, 2008.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
The earnings release will be available on the investor relations page of its website at http://www.wuxipharmatech.com .
Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (Eastern) / 5:00 am (Pacific) / 8:00 pm (Beijing/Hong Kong) on Wednesday, May 28, 2008 to discuss its 2008 first quarter financial results and recent business activity. The conference call may be accessed by calling:
A telephone replay will be available shortly after the call until June 26, 2008 at (US) +1 866-883-4489, +1 718-354-1112 / (HK) +852 3002-1607. Passcode: 5274714#.
A live webcast of the conference call and replay will be available on the investor relations page of WuXi PharmaTech's website at http://www.wuxipharmatech.com .
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. For more information, please visit: http://www.wuxipharmatech.com .
CONTACT: Investor Contact - Dr. Hai Mi, Vice President, Corporate
Communications of WuXi PharmaTech (Cayman) Inc., +86-21-5046-3726, or
ir@pharmatechs.com; Investor Relations (US): Mahmoud Siddig, Director of
Taylor Rafferty, +1-212-889-4350, or pharmatechs@taylor-rafferty.com;
Investor Relations (HK): Ruby Yim, Managing Director of Taylor Rafferty,
+852-3196-3712, or pharmatechs@taylor-rafferty.com; Media Contact - John
Dudzinsky, Director of Taylor Rafferty, +1-212-889-4350, or
pharmatechs@taylor-rafferty.com
Web site: http://www.wuxipharmatech.com/
